Skip to main content

Research Repository

Advanced Search

Projects (551)

Developing and testing weight management interventions to improve outcomes for seldom reached women affected by obesity and diagnosed with breast cancer - the FORALL study Jul 1, 2024 - Jun 30, 2025
Background
Women and men living in the most deprived areas are more likely to be affected by obesity than those living in the least deprived areas, and experience poorer outcomes following a diagnosis of cancer. Obesity is linked to the risk of pros... Read More about Developing and testing weight management interventions to improve outcomes for seldom reached women affected by obesity and diagnosed with breast cancer - the FORALL study.

Co-developing and piloting a whole-ward music therapy intervention to reduce agitation and related physical assaults on inpatient psychiatric wards for people with dementia: The MELODIC Study (Music therapy Embedded in the Life Of Dementia Inpatient Care) Sep 1, 2023 - Feb 28, 2025
Psychiatric inpatient wards for people living with dementia (PwD) provide specialist support for the most unwell PwD under the care of the local NHS mental health trust. The main reasons for admission are the behavioural and psychological symptoms of... Read More about Co-developing and piloting a whole-ward music therapy intervention to reduce agitation and related physical assaults on inpatient psychiatric wards for people with dementia: The MELODIC Study (Music therapy Embedded in the Life Of Dementia Inpatient Care).

Equipment - orbital shaker Aug 1, 2022 - Jul 31, 2023
Endometriosis affects 1 in 10 women worldwide, the same frequency as diabetes but it has had a tiny amount of research funding in comparison. Endometriosis causes debilitating pain that can lead to loss of work, impact mental health and is a major ca... Read More about Equipment - orbital shaker.

TARGETING THE MYOSIN LIGHT CHAIN PHOSPHATASE WITH PEPTIDE DISRUPTORS: A NOVEL ANTIPLATELET THERAPEUTIC APPROACH Jul 3, 2023 - Jul 2, 2026
Platelet activation and thrombus formation play key roles in the pathogenesis of ischaemic cardiovascular diseases, one of the major causes of death in the UK. Many antiplatelet agents have been developed to manage these conditions; however, they are... Read More about TARGETING THE MYOSIN LIGHT CHAIN PHOSPHATASE WITH PEPTIDE DISRUPTORS: A NOVEL ANTIPLATELET THERAPEUTIC APPROACH.

CRN funding - HYPER AID Aug 1, 2022 - Mar 31, 2023
0.5 funding for Dana Schofield for 8 months from 01/08/2022 - 31/03/2023
Support a concerted effort to maximise recruitment to this Diabetes study in Yorkshire and Humber. Although recruitment target has been met, global recruitment (nationally) is... Read More about CRN funding - HYPER AID.

SURPASS EARLY: A Randomised, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes Sep 1, 2022 - Aug 31, 2027
A Randomised, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes (SURP... Read More about SURPASS EARLY: A Randomised, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes.